Lafarge-Frayssinet C - Search Results

1

Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA.

Ellouk-Achard S, Djenabi S, De Oliveira GA, Desauty G, Duc HT, Zohair M, Trojan J, Claude JR, Sarasin A, Lafarge-Frayssinet C. Ellouk-Achard S, et al. Among authors: lafarge frayssinet c. J Hepatol. 1998 Nov;29(5):807-18. doi: 10.1016/s0168-8278(98)80263-8. J Hepatol. 1998. PMID: 9833920

2

Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.

Lafarge-Frayssinet C, Duc HT, Frayssinet C, Sarasin A, Anthony D, Guo Y, Trojan J. Lafarge-Frayssinet C, et al. Cancer Gene Ther. 1997 Sep-Oct;4(5):276-85. Cancer Gene Ther. 1997. PMID: 9345599

3

Adenovirus-mediated anti insulin-like growth factor I gene transfer for the treatment of hepatocellular carcinoma.

Lafarge-Frayssinet C, Martin C, Van Binh PN, Achard-Ellouk S, Duc HT, Frayssinet C, Cardoso G, Desauty G, Warnet JM, Bréchot C, Sarasin A. Lafarge-Frayssinet C, et al. Anticancer Res. 2002 Nov-Dec;22(6C):3895-904. Anticancer Res. 2002. PMID: 12553010

4

[Immunotherapy of tumors expressing IGF-I].

Trojan J, Duc HT, Lafarge-Frayssinet C, Upegui-Gonzales LC, Swiercz B, Bismuth H, Hor F, Anthony D, Guo Y, Ilan J. Trojan J, et al. Among authors: lafarge frayssinet c. C R Seances Soc Biol Fil. 1996;190(1):165-9. C R Seances Soc Biol Fil. 1996. PMID: 8881277 French.

5

Use of the IGF-I antisense strategy in the treatment of the hepatocarcinoma.

Upegui-Gonzalez LC, Duc HT, Buisson Y, Arborio M, Lafarge-Frayssinet C, Jasmin C, Guo Y, Trojan J. Upegui-Gonzalez LC, et al. Among authors: lafarge frayssinet c. Adv Exp Med Biol. 1998;451:35-42. doi: 10.1007/978-1-4615-5357-1_6. Adv Exp Med Biol. 1998. PMID: 10026847 No abstract available.

6

Stimulation of anti-melanoma immune effectors via modified tumour cells exhibiting inhibited IGF-I and low CD9.

Trabado S, Van Binh PN, Martin C, Lafarge-Frayssinet C, Lone YC, Trojan J, Warnet JM, Duc HT. Trabado S, et al. Among authors: lafarge frayssinet c. Biomed Pharmacother. 2007 Sep;61(8):494-8. doi: 10.1016/j.biopha.2007.07.004. Epub 2007 Aug 7. Biomed Pharmacother. 2007. PMID: 17764889

7

Cellular genes possibly involved in the transformation process of the human melanoma cell line XP44 RO (Mel).

Lafarge-Frayssinet C, Daya-Grosjean L, Estrade S, Frezouls G, Sarasin A, Cassingena R. Lafarge-Frayssinet C, et al. Anticancer Res. 1995 Jul-Aug;15(4):1205-13. Anticancer Res. 1995. PMID: 7654000

8

Modulated expression of cell surface molecules and in vivo outgrowth of modified melanoma cells.

Trabado S, Nguyen Van Binh P, Martin C, Lafarge-Frayssinet C, Thevenin M, Baudouin F, Warnet JM, Duc HT. Trabado S, et al. Among authors: lafarge frayssinet c. Biomed Pharmacother. 2006 Dec;60(10):693-7. doi: 10.1016/j.biopha.2006.09.009. Epub 2006 Oct 19. Biomed Pharmacother. 2006. PMID: 17071049

9

Activation of an alpha-fetoprotein/receptor pathway in human normal and malignant peripheral blood mononuclear cells.

Esteban C, Trojan J, Macho A, Mishal Z, Lafarge-Frayssinet C, Uriel J. Esteban C, et al. Leukemia. 1993 Nov;7(11):1807-16. Leukemia. 1993. PMID: 7694005

10

Endogenous and exogenous alpha-fetoproteins as differential markers of cultured neonatal mouse Schwann cells and fibroblasts.

Trojan J, Boutry JM, Hauw JJ, Lafarge-Frayssinet C, Deugnier MA, Hajeri-Germond M, Abramsky O, Uriel J. Trojan J, et al. Dev Neurosci. 1992;14(4):296-307. doi: 10.1159/000111675. Dev Neurosci. 1992. PMID: 1284239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters